MGNX logo

MacroGenics, Inc.

MGNX
0.00
USD
+0.00+0.00%

MacroGenics, Inc. at a glance

Open MGNX on Vela

MacroGenics, Inc. (MGNX) is a Healthcare company in the Biotechnology industry, headquartered in Rockville, MD, with about 293 employees. Its shares trade on NASDAQ, and its IPO date is October 10, 2013. With a market capitalization of $143.3 million, MGNX is a small-cap stock.

It trades an average of 805,826 shares a day.

In its latest reported quarter (results released August 13, 2026), MacroGenics, Inc. posted revenue of $32.8 million and earnings of $0.31 per share, against estimates of $59.1 million and -$0.08.

Figures as of October 25, 2026, from market data providers. Descriptive only, not financial advice.

MGNX: Frequently asked questions

As of October 25, 2026, MacroGenics, Inc. has a market capitalization of $143.3 million, making it a small-cap company in the Healthcare sector.

Figures update throughout the day from market data providers. Nothing on this page is financial advice.